BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26863209)

  • 41. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.
    Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD
    PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.
    Miyagawa K; Shi M; Chen PI; Hennigs JK; Zhao Z; Wang M; Li CG; Saito T; Taylor S; Sa S; Cao A; Wang L; Snyder MP; Rabinovitch M
    Circ Res; 2019 Jan; 124(2):211-224. PubMed ID: 30582451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
    Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
    Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross talk between Smad, MAPK, and actin in the etiology of pulmonary arterial hypertension.
    West J
    Adv Exp Med Biol; 2010; 661():265-78. PubMed ID: 20204736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.
    Dannewitz Prosseda S; Tian X; Kuramoto K; Boehm M; Sudheendra D; Miyagawa K; Zhang F; Solow-Cordero D; Saldivar JC; Austin ED; Loyd JE; Wheeler L; Andruska A; Donato M; Wang L; Huebner K; Metzger RJ; Khatri P; Spiekerkoetter E
    Am J Respir Crit Care Med; 2019 Jan; 199(1):83-98. PubMed ID: 30107138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRISPR-mediated Bmpr2 point mutation exacerbates late pulmonary vasculopathy and reduces survival in rats with experimental pulmonary hypertension.
    Kabwe JC; Sawada H; Mitani Y; Oshita H; Tsuboya N; Zhang E; Maruyama J; Miyasaka Y; Ko H; Oya K; Ito H; Yodoya N; Otsuki S; Ohashi H; Okamoto R; Dohi K; Nishimura Y; Mashimo T; Hirayama M; Maruyama K
    Respir Res; 2022 Apr; 23(1):87. PubMed ID: 35395852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle.
    Hagen M; Fagan K; Steudel W; Carr M; Lane K; Rodman DM; West J
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1473-9. PubMed ID: 17322283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension.
    Soon E; Crosby A; Southwood M; Yang P; Tajsic T; Toshner M; Appleby S; Shanahan CM; Bloch KD; Pepke-Zaba J; Upton P; Morrell NW
    Am J Respir Crit Care Med; 2015 Oct; 192(7):859-72. PubMed ID: 26073741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exogenous serotonin regulates proliferation of interstitial cells of Cajal in mouse jejunum through 5-HT2B receptors.
    Wouters MM; Gibbons SJ; Roeder JL; Distad M; Ou Y; Strege PR; Szurszewski JH; Farrugia G
    Gastroenterology; 2007 Sep; 133(3):897-906. PubMed ID: 17854596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension.
    Ihida-Stansbury K; McKean DM; Lane KB; Loyd JE; Wheeler LA; Morrell NW; Jones PL
    Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L694-702. PubMed ID: 16782755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension.
    Frump AL; Lowery JW; Hamid R; Austin ED; de Caestecker M
    PLoS One; 2013; 8(11):e80319. PubMed ID: 24224048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
    Li W; Hu H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
    Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
    Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.
    Talati MH; Brittain EL; Fessel JP; Penner N; Atkinson J; Funke M; Grueter C; Jerome WG; Freeman M; Newman JH; West J; Hemnes AR
    Am J Respir Crit Care Med; 2016 Sep; 194(6):719-28. PubMed ID: 27077479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial-to-mesenchymal transition in pulmonary hypertension.
    Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
    Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Hemnes AR; Fessel JP; Chen X; Zhu S; Fortune NL; Jetter C; Freeman M; Newman JH; West JD; Talati MH
    Am J Physiol Lung Cell Mol Physiol; 2020 Feb; 318(2):L429-L441. PubMed ID: 31850803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension.
    Reynolds AM; Xia W; Holmes MD; Hodge SJ; Danilov S; Curiel DT; Morrell NW; Reynolds PN
    Am J Physiol Lung Cell Mol Physiol; 2007 May; 292(5):L1182-92. PubMed ID: 17277049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension.
    Bisserier M; Katz MG; Bueno-Beti C; Brojakowska A; Zhang S; Gubara S; Kohlbrenner E; Fazal S; Fargnoli A; Dorfmuller P; Humbert M; Hata A; Goukassian DA; Sassi Y; Hadri L
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BMP pathway regulation of and by macrophages.
    Talati M; West J; Zaynagetdinov R; Hong CC; Han W; Blackwell T; Robinson L; Blackwell TS; Lane K
    PLoS One; 2014; 9(4):e94119. PubMed ID: 24713633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.